Papers
Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
BMJ 1994; 308 doi: https://doi.org/10.1136/bmj.308.6922.159 (Published 15 January 1994) Cite this as: BMJ 1994;308:159
Related articles
- No related articles found.
See more
- Sixty seconds on . . . 10 000 stepsBMJ March 08, 2024, 384 q598; DOI: https://doi.org/10.1136/bmj.q598
- Scarlett McNally: Enabling active travel can improve the UK’s healthBMJ March 06, 2024, 384 q522; DOI: https://doi.org/10.1136/bmj.q522
- Scarlett McNally: Boosting swimming for health and joyBMJ February 20, 2024, 384 q393; DOI: https://doi.org/10.1136/bmj.q393
- Variability in blood pressure could help predict heart attack and stroke risk, researchers sayBMJ February 09, 2024, 384 q363; DOI: https://doi.org/10.1136/bmj.q363
- Scarlett McNally: Preventing obesity is different from curing it—and even more urgentBMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134
Cited by...
- Update on Cardiac Catheterization in Patients With Prior Coronary Artery Bypass Graft Surgery
- A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative
- Early Aspirin administration post Coronary Artery Bypass Graft Surgery - Changing hospital culture through a two-cycled audit
- Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG: FREEDOM Insights
- Surgeon Case Volume and 30-Day Mortality After Carotid Endarterectomy Among Contemporary Medicare Beneficiaries: Before and After National Coverage Determination for Carotid Artery Stenting
- Medical Therapy in Peripheral Artery Disease
- Relationship Between Vein Graft Failure and Subsequent Clinical Outcomes After Coronary Artery Bypass Surgery
- Exploring Mechanisms of Graft Occlusion: Toward Improved Outcomes in Coronary Artery Bypass Graft Surgery
- Iliac Venous Stenting: Antithrombotic Efficacy of PD0348292, an Oral Direct Factor Xa Inhibitor, Compared With Antiplatelet Agents in Pigs
- Multimodal Thromboprophylaxis for Total Hip and Knee Arthroplasty Based on Risk Assessment
- Prevention of Platelet Glycoprotein IIb/IIIa Activation by 3,4-Methylenedioxy-beta-Nitrostyrene, A Novel Tyrosine Kinase Inhibitor
- Peripheral Arterial Disease in Patients With Diabetes
- Indirect comparison meta-analysis of aspirin therapy after coronary surgery
- Principles From Clinical Trials Relevant to Clinical Practice: Part I
- Mapping of a Ligand-binding Site for the Human Thromboxane A2 Receptor Protein
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
- Managing peripheral arterial disease in primary care
- Evidence-Based Risk Assessment in Noninvasive Imaging
- Superiority of Clopidogrel Versus Aspirin in Patients With Prior Cardiac Surgery
- Increased platelet reactivity and significant changes in coagulation markers after cavopulmonary connection
- Increased Platelet Sensitivity to Collagen in Individuals Resistant to Low-Dose Aspirin
- Reduction in Vascular Lesion Formation by Hirudin Secreted From Retrovirus-Transduced Confluent Endothelial Cells on Vascular Grafts in Baboons
- Randomised controlled trials in cardiovascular medicine: past achievements, future challenges
- Clopidogrel Inhibition of Stent, Graft, and Vascular Thrombogenesis With Antithrombotic Enhancement by Aspirin in Nonhuman Primates
- Oral Platelet Glycoprotein IIb/IIIa Receptor Antagonists: The Present Challenge Is Safety
- Profound and Sustained Inhibition of Platelet Aggregation by Fradafiban, a Nonpeptide Platelet Glycoprotein IIb/IIIa Antagonist, and Its Orally Active Prodrug, Lefradafiban, in Men
- ACC/AHA guidelines for the management of patients with acute myocardial infarction: A report of the American College of cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
- Late Outcome After Coronary Artery Bypass Graft Surgery in Patients <40 Years Old
- Gene therapy for the vulnerable plaque
- Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials
- ANTIPLATELET THERAPY AND ARTERIAL PATENCY
- Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients